(Moderna Inc.) Biotech company Moderna Inc. has inked a deal with the Canadian government to build a state-of-the-art messenger RNA vaccine manufacturing facility in the country.
The manufacturing facility is intended to enhance access to domestically produced vaccines in Canada.
Moderna expects the collaboration to strengthen Canada’s rapid pandemic response capabilities.
The biotech firm expects to replicate the sustainable national business model with Canada to other geographies.
MRNA: NASDAQ is down -3.54%.
